Insulet Corporation provided revenue guidance for the second quarter ending June 30, 2024. For the quarter ending June 30, 2024, the company expects revenue growth of 15% to 18%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
177.8 USD | -1.25% | -2.72% | -18.05% |
May. 14 | Insulet Shares Rise Despite Blue Orca's Short Position | MT |
May. 10 | Raymond James Adjusts Price Target on Insulet to $213 From $218 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.05% | 12.61B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+6.18% | 40.74B | |
+19.92% | 31.6B | |
+15.73% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Insulet Corporation Provides Revenue Guidance for the Second Quarter Ending June 30, 2024